Marking World Cancer Day, IIT Madras on Wednesday released India’s first comprehensive genome database covering paediatric leukaemia, colorectal and pancreatic cancers. The publicly accessible Bharat Cancer Genome Atlas (BCGA) is expected to significantly advance cancer research and precision oncology in India.

Developed under the Bharat Cancer Genome Grid (BCG2) initiative, the project addresses India’s long-standing under-representation in global cancer genome studies. According to the Indian Council of Medical Research, one in nine Indians is likely to develop cancer, with incidence rising by 12.8% annually since 2022.

The initiative was led by IIT Madras’ Centre of Excellence on Cancer Genomics and Molecular Therapeutics, with principal support from Hyundai Motor India through its Hyundai Hope for Cancer program. Whole genome sequencing of patient samples collected nationwide was carried out in collaboration with leading hospitals and research partners.

Announcing the launch, IIT Madras director Prof V Kamakoti said the atlas fills a critical gap in understanding India-specific cancer genetics and will aid early diagnosis, disease monitoring and personalized treatment. Project Coordinator Prof. S. Mahalingam added that the database will help identify biomarkers and novel therapeutic targets tailored to Indian populations.

The BCGA is now accessible to researchers and clinicians in India and abroad at bcga.iitm.ac.in, supporting India’s shift toward precision and personalised cancer care.

Also read: JGU launches World University Leaders Forum at World Economic Forum, Davos